Covalon Technologies Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CVALF research report →
About the company
Covalon Technologies Ltd. is a global medical technology firm specializing in the innovation, production, commercialization, and licensing of medical solutions across the United States, Canada, Europe, the Middle East, Asia, and Latin America. The company's operations are built upon three distinct proprietary technological platforms.
- CEO
- Brent Ashton
- IPO
- 2007
- Employees
- 105
- HQ
- Mississauga, ON, CA
Price Chart
- Market Cap
- $40.87M
- P/E
- 34.84
- P/S
- 1.76
- P/B
- 2.05
- EV/EBITDA
- 20.41
- Div Yield
- 7.21%
- Gross Margin
- 52.96%
- Op Margin
- 3.49%
- Net Margin
- 5.02%
- ROE
- 5.72%
- ROIC
- 3.82%
- Revenue
- $32.82M · 5.29%
- Net Income
- $2.06M · -22.91%
- EPS
- $0.08 · -31.64%
- Op Income
- $1.76M
- FCF YoY
- -61.35%
- 52W High
- $2.14
- 52W Low
- $1.16
- 50D MA
- $1.48
- 200D MA
- $1.40
- Beta
- 0.01
- Avg Volume
- 6.97K
Get TickerSpark's AI analysis on CVALF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CVALF coverage
Recent articles, reports, and earnings notes.
No research on CVALF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CVALF report →Similar companies
Peers in the same neighborhood.